<DOC>
	<DOCNO>NCT03080480</DOCNO>
	<brief_summary>The purpose propose research investigate efficacy safety therapy pioglitazone chronic granulomatous disease ( CGD ) patient severe infection .</brief_summary>
	<brief_title>Pioglitazone Therapy Chronic Granulomatous Disease</brief_title>
	<detailed_description>Chronic granulomatous disease ( CGD ) rare genetic disease cause defect gene encode subunit nicotinamide adenine dinucleotide（NADPH）phosphate oxidase complex . In normal phagocyte peroxisome proliferator-activated receptor gamma ( PPARγ ) activation link NADPH oxidase activity enhance mitochondrial reactive oxygen specie ( ROS ) production . There deficient mitochondrial ROS production CGD，due lack upstream signal NADPH oxidase PPARγ . These patient susceptible bacterial fungal infection , well extensive tissue granuloma formation . X-chromosome-linked CGD ( X-CGD ) frequently . And generally produce severe phenotype , mortality rate 3 % 5 % per year despite state-of-the-art prophylaxis intensive multimodal treatment . At present curative treatment patient X-CGD hematopoietic stem cell transplantion ( HSCT ) . But many patient without HLA-matched donor active infections/inflammatory complication still require novel approches . PPARγ agonist pioglitazone , approve type 2 diabetes , report bypass need NADPH oxidase enhance mtROS production partially restore host defense CGD . What 's , animal model several clinical case prove efficacy . The investigator propose study efficacy safety therapy pioglitazone child severe infection CGD , long-term effect . Through study investigator hope confirm benefit pioglitazone treatment rare disease especially patient without prompt suitable match donor critical disease condition force postpone HSCT .</detailed_description>
	<mesh_term>Granulomatous Disease , Chronic</mesh_term>
	<mesh_term>Granuloma</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>1 . Age：1 month 18 year 2 . Chronic Granulomatous Disease 3. severe infection 1 . &gt; 18 year age 2. infection treatable conventional therapy ( antibiotic , antimycotic , allogeneic granulocyte )</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chronic Granulomatous Disease</keyword>
	<keyword>Severe Infection</keyword>
	<keyword>PPARγ</keyword>
	<keyword>Pioglitazone</keyword>
	<keyword>phagocyte</keyword>
</DOC>